{"disease":{"id":"primary-malignant-neoplasm-of-gastrointestinal-tract","name":"Primary malignant neoplasm of gastrointestinal tract","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"doxifluridine","indication_name":"Primary malignant neoplasm of gastrointestinal tract","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flutron","generic_name":"DOXIFLURIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"doxifluridine","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"flox","indication_name":"Primary malignant neoplasm of gastrointestinal tract","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLOX","company_name":"Hospira","drug_phase":"marketed","molecular_target":"Thymidylate synthase, Thymidylate synthase","drug_class":"","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"floxuridine","indication_name":"Primary malignant neoplasm of gastrointestinal tract","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fudr","generic_name":"FLOXURIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"Antimetabolite [EPC]","quality_score":55,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02575898","title":"Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}